Restoration of Podocyte Structure and Improvement of Chronic Renal Disease in Transgenic Mice Overexpressing Renin

被引:57
作者
Huby, Anne-Cecile
Rastaldi, Maria-Pia
Caron, Kathleen
Smithies, Oliver
Dussaule, Jean-Claude
Chatziantoniou, Christos
机构
[1] INSERM UMR 702, Paris
[2] Fondazione IRCCS Osp. Magg. Policlin., Fondazione D'Amico per la Ric. sulle Malat. Ren., Milano
[3] Department of Molecular and Cell Physiology, University of North Carolina, Chapel Hill, NC
[4] Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC
[5] Université Pierre et Marie Curie-Paris VI, UMRS 702, Paris
[6] AP-HP, Hôpital St-Antoine, Department of Physiology, Paris
关键词
NITRIC-OXIDE SYNTHESIS; TISSUE GROWTH-FACTOR; MATRIX METALLOPROTEINASES; MESENCHYMAL TRANSITION; GLOMERULAR FIBROSIS; BMP ANTAGONIST; I GENE; REVERSAL; KIDNEY; COLLAGEN;
D O I
10.1371/journal.pone.0006721
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
070301 [无机化学]; 070403 [天体物理学]; 070507 [自然资源与国土空间规划学]; 090105 [作物生产系统与生态工程];
摘要
Background: Proteinuria is a major marker of the decline of renal function and an important risk factor of coronary heart disease. Elevated proteinuria is associated to the disruption of slit-diaphragm and loss of podocyte foot processes, structural alterations that are considered irreversible. The objective of the present study was to investigate whether proteinuria can be reversed and to identify the structural modifications and the gene/protein regulation associated to this reversal. Methodology/Principal Findings: We used a novel transgenic strain of mouse (RenTg) that overexpresses renin at a constant high level. At the age of 12-month, RenTg mice showed established lesions typical of chronic renal disease such as perivascular and periglomerular inflammation, glomerular ischemia, glomerulosclerosis, mesangial expansion and tubular dilation. Ultrastructural analysis indicated abnormal heterogeneity of basement membrane thickness and disappearance of podocyte foot processes. These structural alterations were accompanied by decreased expressions of proteins specific of podocyte (nephrin, podocin), or tubular epithelial cell (E-cadherin and megalin) integrity. In addition, since TGF beta is considered the major pro-fibrotic agent in renal disease and since exogenous administration of BMP7 is reported to antagonize the TGF beta-induced phenotype changes in kidney, we have screened the expressions of several genes belonging in the TGF beta/BMP superfamily. We found that the endogenous inhibitors of BMPs such as noggin and Usag-1 were several-fold activated inhibiting the action of BMPs and thus reinforcing the deleterious action of TGF beta. Treatment with an AT1 receptor antagonist, at dose that did not decrease arterial pressure, gradually reduced albuminuria. This decrease was accompanied by re-expression of podocin, nephrin, E-cadherin and megalin, and reappearance of podocyte foot processes. In addition, expressions of noggin and Usag-1 were markedly decreased, permitting thus activation of the beneficial action of BMPs. Conclusions/Significance: These findings show that proteinuria and alterations in the expression of proteins involved in the integrity and function of glomerular and renal epithelial phenotype are reversible events when the local action of angiotensin II is blocked, and provide hope that chronic renal disease can be efficiently treated.
引用
收藏
页数:9
相关论文
共 41 条
[1]
Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats [J].
Adamczak, M ;
Gross, ML ;
Krtil, J ;
Koch, A ;
Tyralla, K ;
Amann, K ;
Ritz, E .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (11) :2833-2842
[2]
Effect of irbesartan on the antioxidant defence system and nitric oxide release in diabetic rat kidney [J].
Anjaneyulu, M ;
Chopra, K .
AMERICAN JOURNAL OF NEPHROLOGY, 2004, 24 (05) :488-496
[3]
Benigni A, 2001, J AM SOC NEPHROL, V12, P941, DOI 10.1681/ASN.V125941
[4]
Angiotensin II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis - Evidence for an endothelin-mediated mechanism [J].
Boffa, JJ ;
Tharaux, PL ;
Placier, S ;
Ardaillou, R ;
Dussaule, JC ;
Chatziantoniou, C .
CIRCULATION, 1999, 100 (18) :1901-1908
[5]
Regression of renal vascular and glomerular fibrosis: Role of angiotensin II receptor antagonism and matrix metalloproteinases [J].
Boffa, JJ ;
Lu, Y ;
Placier, S ;
Stefanski, A ;
Dussaule, JC ;
Chatziantoniou, C .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (05) :1132-1144
[6]
Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene [J].
Caron, KMI ;
James, LR ;
Kim, HS ;
Knowles, J ;
Uhlir, R ;
Mao, L ;
Hagaman, JR ;
Cascio, W ;
Rockman, H ;
Smithies, O .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (09) :3106-3111
[7]
A genetically clamped renin transgene for the induction of hypertension [J].
Caron, KMI ;
James, LR ;
Kim, HS ;
Morham, SG ;
Lopez, MLSS ;
Gomez, RA ;
Reudelhuber, TL ;
Smithies, O .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (12) :8248-8252
[8]
Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation [J].
Carvajal, Gisselle ;
Rodriguez-Vita, Juan ;
Rodrigues-Diez, Raquel ;
Sanchez-Lopez, Elsa ;
Ruperez, Monica ;
Cartier, Cecile ;
Esteban, Vanesa ;
Ortiz, Alberto ;
Egido, Jesus ;
Mezzano, Sergio A. ;
Ruiz-Ortega, Marta .
KIDNEY INTERNATIONAL, 2008, 74 (05) :585-595
[9]
DIAMOND JR, 1990, AM J PATHOL, V137, P1323
[10]
Renoprotective effect of angiotensin II receptor antagonists in experimental chronic renal failure [J].
Eliahou, H ;
Avinoach, I ;
Shahmurov, M ;
Ben-David, A ;
Shahar, C ;
Matas, Z ;
Zimlichman, R .
AMERICAN JOURNAL OF NEPHROLOGY, 2001, 21 (01) :78-83